Aikaterini Bitsani

Athens, ESYE31 11527, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.

Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.

Journal: Cancers

Published: September 04, 2025

Acalabrutinib resistance in a CLL patient harboring a C515 mutation in the BTK-C isoform.

Acalabrutinib resistance in a CLL patient harboring a C515 mutation in the BTK-C isoform.

Journal: Leukemia & lymphoma

Published: June 16, 2025

Novel isolated mutations at the C515 residue of BTK in a CLL patient associated with acalabrutinib resistance.

Novel isolated mutations at the C515 residue of BTK in a CLL patient associated with acalabrutinib resistance.

Journal: Leukemia & lymphoma

Published: May 16, 2025

Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders.

Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders.

Journal: Annals of hematology

Published: January 08, 2025

The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodes.

The seasonal distribution of immune thrombotic thrombocytopenic purpura is influenced by geography: Epidemiologic findings from a multi-center analysis of 719 disease episodes.

Journal: American journal of hematology

Published: June 07, 2024

Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.

Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study.

Journal: Viruses

Published: June 20, 2023

Antiphospholipid syndrome in cardiovascular disease and cancer.

Antiphospholipid syndrome in cardiovascular disease and cancer.

Journal: European journal of haematology

Published: June 10, 2023

Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data.

Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data.

Journal: Frontiers in medicine

Published: May 20, 2023

Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study.

Factors predicting poor outcomes of patients treated with tocilizumab for COVID‑19‑associated pneumonia: A retrospective study.

Journal: Experimental and therapeutic medicine

Published: August 29, 2022

COVID-19-associated pneumonia in Swyer-James-MacLeod syndrome: A case report.

COVID-19-associated pneumonia in Swyer-James-MacLeod syndrome: A case report.

Journal: Medicine international

Published: August 05, 2022

COVID-19 induced hypoparathyroidism: A case report.

COVID-19 induced hypoparathyroidism: A case report.

Journal: Experimental and therapeutic medicine

Published: February 15, 2022

Exacerbation of bronchiectasis by Pseudomonas putida complicating COVID-19 disease: A case report.

Exacerbation of bronchiectasis by Pseudomonas putida complicating COVID-19 disease: A case report.

Journal: Experimental and therapeutic medicine

Published: September 13, 2021

Showing 1-12 of 19

Last Updated: 09/26/2026